Holmes Biopharma, Inc. (LMB) Reports Q2 EPS of $0.09, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus
Go back to Holmes Biopharma, Inc. (LMB) Reports Q2 EPS of $0.09, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 45.54 +1.34 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.20 | 52 Week High | $0.15 | |||
| Open | $44.39 | 52 Week Low | $0.15 | |||
| Day High | $45.75 | P/E | N/A | |||
| Day Low | $44.28 | EPS | $0.00 | |||
| Volume | 529,386 | |||||
